TYK2 inhibition and its potential in the treatment of chronic inflammatory immune diseases-Reference-Cited by-同舟云学术

TYK2 inhibition and its potential in the treatment of chronic inflammatory immune diseases

Published:2021-09-27 Issue:10 Volume:19 Page:1409-1420
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft

Author:

Ghoreschi Kamran¹,Augustin Matthias²,Baraliakos Xenofon³,Krönke Gerhard⁴,Schneider Matthias⁵,Schreiber Stefan⁶,Schulze‐Koops Hendrik⁷,Zeißig Sebastian⁸,Thaçi Diamant⁹

Affiliation:

1. Department of Dermatology Venereology and Allergology Charité – Universitätsmedizin Berlin Berlin Germany

2. Institute for Health Services Research in Dermatology and Nursing University Medical Center Hamburg Hamburg Germany

3. Center for Rheumatology Katholische Kliniken Rhein‐Ruhr Herne Germany

4. Clinic for Inner Medicine 3 (Rheumatology and Immunology) University Hospital Erlangen Erlangen Germany

5. Polyclinic and Functional Area for Rheumatology University Hospital Düsseldorf Düsseldorf Germany

6. Institute of Clinical Molecular Biology Christian Albrechts University Kiel Kiel Germany

7. Division of Rheumatology and Clinical Immunology Department of Medicine IV University of Munich Munich Germany

8. Medical Clinic I – University Hospital Dresden and Center for Regenerative Therapies Dresden (CRTD) Dresden Germany

9. Institute for Inflammatory Medicine University Hospital Schleswig‐Holstein Campus Lübeck Lübeck Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ddg.14585

Reference60 articles.

1. Epidemiology of Immune-Mediated Inflammatory Diseases: Incidence, Prevalence, Natural History, and Comorbidities

2. The 3 major types of innate and adaptive cell-mediated effector immunity

3. Zytokine

4. S3 Guideline for the treatment of psoriasis vulgaris, update – Short version part 1 – Systemic treatment;Nast A;J Dtsch Dermatol Ges,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signaling pathways and targeted therapies for psoriasis;Signal Transduction and Targeted Therapy;2023-11-27

2. Quercetin as a possible complementary therapy in multiple sclerosis: Anti-oxidative, anti-inflammatory and remyelination potential properties;Heliyon;2023-11

3. The Relationship between COVID-19 Severity in Children and Immunoregulatory Gene Polymorphism;Viruses;2023-10-14

4. Identifying pathogenic variants related to systemic lupus erythematosus by integrating genomic databases and a bioinformatic approach;Genomics & Informatics;2023-09-30

5. Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279;Journal of Medicinal Chemistry;2023-07-10